NAMS Long Put Strategy
NAMS (NewAmsterdam Pharma Company N.V.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
NAMS (NewAmsterdam Pharma Company N.V.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $4.41B, a beta of 0.03 versus the broader market, a 52-week range of 16.785-42.205, average daily share volume of 1.0M, a public-listing history dating back to 2021, approximately 68 full-time employees. These structural characteristics shape how NAMS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.03 indicates NAMS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long put on NAMS?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current NAMS snapshot
As of May 15, 2026, spot at $35.32, ATM IV 77.30%, IV rank 33.61%, expected move 22.16%. The long put on NAMS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long put structure on NAMS specifically: NAMS IV at 77.30% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 22.16% (roughly $7.83 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NAMS expiries trade a higher absolute premium for lower per-day decay. Position sizing on NAMS should anchor to the underlying notional of $35.32 per share and to the trader's directional view on NAMS stock.
NAMS long put setup
The NAMS long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NAMS near $35.32, the first option leg uses a $35.32 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NAMS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NAMS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $35.32 | N/A |
NAMS long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
NAMS long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on NAMS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on NAMS
Long puts on NAMS hedge an existing long NAMS stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying NAMS exposure being hedged.
NAMS thesis for this long put
The market-implied 1-standard-deviation range for NAMS extends from approximately $27.49 on the downside to $43.15 on the upside. A NAMS long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long NAMS position with one put per 100 shares held. Current NAMS IV rank near 33.61% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on NAMS should anchor more to the directional view and the expected-move geometry. As a Healthcare name, NAMS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NAMS-specific events.
NAMS long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NAMS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NAMS alongside the broader basket even when NAMS-specific fundamentals are unchanged. Long-premium structures like a long put on NAMS are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current NAMS chain quotes before placing a trade.
Frequently asked questions
- What is a long put on NAMS?
- A long put on NAMS is the long put strategy applied to NAMS (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With NAMS stock trading near $35.32, the strikes shown on this page are snapped to the nearest listed NAMS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are NAMS long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the NAMS long put priced from the end-of-day chain at a 30-day expiry (ATM IV 77.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NAMS long put?
- The breakeven for the NAMS long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NAMS market-implied 1-standard-deviation expected move is approximately 22.16%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on NAMS?
- Long puts on NAMS hedge an existing long NAMS stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying NAMS exposure being hedged.
- How does current NAMS implied volatility affect this long put?
- NAMS ATM IV is at 77.30% with IV rank near 33.61%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.